HBW
GEHC icon

Hazlett, Burt & Watson’s GE HealthCare GEHC Stock Holding History

Hazlett, Burt & Watson’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Sell
82
-60
-42% -$3.94K ﹤0.01% 771
2026
Q1 		$11K Hold
142
– – ﹤0.01% 677
2025
Q4 		$12K Sell
142
-40
-22% -$3.12K ﹤0.01% 677
2025
Q3 		$15K Buy
182
+86
+90% +$6.41K 0.01% 609
2025
Q2 		$7K Sell
96
-238
-71% -$16.6K ﹤0.01% 635
2025
Q1 		$27K Sell
334
-387
-54% -$33.3K 0.01% 453
2024
Q4 		$57K Hold
721
– – 0.03% 345
2024
Q3 		$67K Buy
721
+639
+779% +$53.6K 0.03% 318
2024
Q2 		$7K Sell
82
-23
-22% -$1.88K ﹤0.01% 551
2024
Q1 		$9K Sell
105
-15
-13% -$1.25K 0.01% 522
2023
Q4 		$10K Sell
120
-333
-74% -$23.3K 0.01% 496
2023
Q3 		$31K Buy
453
+1
+0.2% +$73 0.02% 361
2023
Q2 		$37K Sell
452
-19
-4% -$1.52K 0.03% 342
2023
Q1 		$39K Buy
+471
New +$33.6K 0.03% 310

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Hazlett, Burt & Watson's GEHC Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its GE HealthCare (GEHC) stake by 42% in Q2 2026, selling an estimated $3.94K and leaving 82 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Hazlett, Burt & Watson first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $67K in Q3 2024. 1,228 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Hazlett, Burt & Watson held 82 shares of GE HealthCare worth $5K as of Q2 2026.
  • Hazlett, Burt & Watson sold 60 GE HealthCare shares in Q2 2026, an estimated $3.94K.
  • GE HealthCare made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #771 holding.
  • Hazlett, Burt & Watson first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Hazlett, Burt & Watson's GE HealthCare position peaked at $67K in Q3 2024.
  • 1,228 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.